SPONSOR
Shanghai Hengrui Pharmaceutical Co., Ltd.
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 2, Phase 2, Phase 1
Shanghai Hengrui Pharmaceutical Co., Ltd. is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Advanced Solid Tumors, High-risk NMIBC, Pain, Advanced Solid Tumor.
The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Hengrui Pharmaceutical Co., Ltd.
How many clinical trials has Shanghai Hengrui Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd., of which 5 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumors, High-risk NMIBC, Pain. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Hengrui Pharmaceutical Co., Ltd. research focus on?
Shanghai Hengrui Pharmaceutical Co., Ltd. clinical trials span Advanced Solid Tumors, High-risk NMIBC, Pain, Advanced Solid Tumor. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Hengrui Pharmaceutical Co., Ltd. clinical trial?
To participate in a Shanghai Hengrui Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Hengrui Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shanghai Hengrui Pharmaceutical Co., Ltd.
NCT06605222 Phase 1, Phase 2
Recruiting
A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
Advanced Solid Tumors
NCT05410730 Phase 1, Phase 2
Recruiting
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
High-risk NMIBC
NCT06895928 Phase 2
Recruiting
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
Advanced Solid Tumors
NCT07301333 Phase 1
Recruiting
A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
Pain
NCT05836948 Phase 1
Recruiting
The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors
Advanced Solid Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology